These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34185142)

  • 1. Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region.
    Uramoto H; Takiguchi T; Koizumi T; Tanimoto A; Hayashi R; Nakazawa Y; Ito KI; Nakada M; Hirono Y; Nishino Y; Yano S
    J Cancer Res Clin Oncol; 2022 May; 148(5):1153-1158. PubMed ID: 34185142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
    Baas P; Daumont MJ; Lacoin L; Penrod JR; Carroll R; Venkatesan S; Ubhi H; Calleja A; Snee M
    Lung Cancer; 2021 Dec; 162():185-193. PubMed ID: 34823894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
    Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
    Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
    Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
    Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database.
    Bou-Samra P; Chang A; Azari F; Kennedy G; Segil A; Guo E; Marmarelis M; Langer C; Singhal S
    Cancer Med; 2023 Jun; 12(11):12208-12220. PubMed ID: 37062067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
    Multidisciplinary Committee of Oncology, Chinese Physicians Association
    Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
    Linton A; Soeberg M; Broome R; Kao S; van Zandwijk N
    Respirology; 2017 Jul; 22(5):978-985. PubMed ID: 28139858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
    Saddoughi SA; Abdelsattar ZM; Blackmon SH
    Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant pleural mesothelioma].
    Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
    Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).
    Raynaud C; Greillier L; Mazieres J; Monnet I; Mastroianni B; Robinet G; Fraboulet G; Dixmier A; Berard H; Lamy R; Letreut J; Lena H; Oliviero G; Botta S; Vergnenegre A; Borget I; Chouaid C
    BMC Cancer; 2015 Nov; 15():857. PubMed ID: 26546402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
    Novello S; Pinto C; Torri V; Porcu L; Di Maio M; Tiseo M; Ceresoli G; Magnani C; Silvestri S; Veltri A; Papotti M; Rossi G; Ricardi U; Trodella L; Rea F; Facciolo F; Granieri A; Zagonel V; Scagliotti G
    Crit Rev Oncol Hematol; 2016 Aug; 104():9-20. PubMed ID: 27286698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia-Pacific Region.
    Ke H; Kao S; Lee K; Takahashi K; Goh HP; Linton A
    Asia Pac J Clin Oncol; 2022 Jun; 18(3):177-190. PubMed ID: 34161674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
    Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
    Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
    Remon J; Nadal E; Dómine M; Ruffinelli J; García Y; Pardo JC; López R; Cilleruelo A; García-Campelo R; Martín P; Juan O; González-Larriba JL; Provencio M; Olmedo E; Ponce S; Cumplido D; Barenys C; Majem M; Massutti B; Rodriguez-Abreu D; Porta R; Sala MA; Martinez-Kareaga M; Lianes P; Reguart N
    Lung Cancer; 2020 Sep; 147():83-90. PubMed ID: 32682189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
    Lin RT; Chang YY; Wang JD; Lee LJ
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.
    Soeberg MJ; Leigh J; Driscoll T; Armstrong B; Young JM; van Zandwijk N
    Occup Environ Med; 2016 Mar; 73(3):187-94. PubMed ID: 26800709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
    Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant pleural mesothelioma in Finland: regional and gender variation.
    Laaksonen S; Ilonen I; Kuosma E; Sutinen E; Wolff H; Vehmas T; Husgafvel-Pursiainen K; Salo JA; Koli K; Räsänen J; Myllärniemi M
    Acta Oncol; 2019 Jan; 58(1):38-44. PubMed ID: 30375909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study.
    Nagamatsu Y; Oze I; Aoe K; Hotta K; Kato K; Nakagawa J; Hara K; Kishimoto T; Fujimoto N
    BMC Cancer; 2018 Mar; 18(1):350. PubMed ID: 29587685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.